Biopharma firm Astellas announces major expansion in Tralee
Astellas Pharma is expanding its biopharmaceutical manufacturing facility in Tralee, Ireland, with a new investment aimed at doubling drug production. The project is expected to create highly skilled jobs and is supported by IDA Ireland, with the new facility slated to open in 2027.
Why it matters
This investment signals continued growth in the Irish pharmaceutical sector and strengthens global supply chains for specialized medicines.
At the announcement of a new investment at the Astellas plant in Tralee were IDA Ireland executive director Mary Buckley; Astellas Ireland head of international business Caroline Mullins; Suzanne Geraghty, Head of Astellas Dublin plant; Peter Carney, Astellas market access and Government Affairs lead Ireland; Ketsuya Kawasako, Astellas Ireland head of pharma manufacturing and president of Astellas Ireland Co; equality minister Norma Foley; IDA Ireland project manager Dee Moran; Louis Collins, head of Astellas Kerry plant; Ray O’Connor,IDA Ireland head of regions;, Emily Ging, head of pharma manufacturing finance; and Owen Moore, head of Astellas Tralee plant. Picture: Don MacMonagle
Astellas Ireland is expanding its biopharmaceutical manufacturing facility and recruiting for new jobs at the Kerry Technology Park in Tralee in an investment which will double drug product manufacturing at its Irish facility.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in